ExodusPoint Capital Management’s Revolution Medicines RVMD Stock Holding History

ExodusPoint Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Buy	+10,536	New	+$1.06M	0.01%	989
2025 Q4	–	Sell	-31,591	Closed	-$1.48M	–	1995
2025 Q3	$1.48M	Sell	31,591 -39,599	-56%	-$1.55M	0.02%	832
2025 Q2	$2.62M	Buy	71,190 +60,839	+588%	+$2.34M	0.02%	641
2025 Q1	$366K	Sell	10,351 -112,964	-92%	-$4.59M	﹤0.01%	1189
2024 Q4	$5.39M	Buy	+123,315	New	+$6.22M	0.04%	427
2024 Q1	–	Sell	-39,719	Closed	-$1.14M	–	1904
2023 Q4	$1.14M	Sell	39,719 -112,571	-74%	-$2.7M	0.01%	769
2023 Q3	$4.21M	Buy	+152,290	New	+$4.52M	0.04%	418
2022 Q4	–	Sell	-38,676	Closed	-$763K	–	2061
2022 Q3	$763K	Sell	38,676 -90	-0.2%	-$1.98K	0.01%	1216
2022 Q2	$756K	Buy	38,766 +16,579	+75%	+$323K	0.01%	1194
2022 Q1	$566K	Buy	22,187 +11,961	+117%	+$260K	0.01%	1455
2021 Q4	$257K	Buy	+10,226	New	+$288K	﹤0.01%	1717
2021 Q2	–	Sell	-8,662	Closed	-$397K	–	2740
2021 Q1	$397K	Sell	8,662 -5,172	-37%	-$232K	0.01%	1504
2020 Q4	$548K	Buy	+13,834	New	+$547K	0.01%	1187

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ExodusPoint Capital Management's RVMD Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Revolution Medicines (RVMD) in Q1 2026: 10,536 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #989 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in RVMD as recently as Q3 2025.

ExodusPoint Capital Management first reported a position in RVMD in Q4 2020 and has held it in 13 quarters since. The position peaked at $5.39M in Q4 2024. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

ExodusPoint Capital Management held 10,536 shares of Revolution Medicines worth $1.02M as of Q1 2026.
Revolution Medicines was a new ExodusPoint Capital Management position in Q1 2026.
Revolution Medicines made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #989 holding.
ExodusPoint Capital Management first reported a position in Revolution Medicines in Q4 2020 and has held it in 13 quarters since.
ExodusPoint Capital Management's Revolution Medicines position peaked at $5.39M in Q4 2024.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.